<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02524002</url>
  </required_header>
  <id_info>
    <org_study_id>22375</org_study_id>
    <nct_id>NCT02524002</nct_id>
  </id_info>
  <brief_title>Enhanced vs. Routine Clear Liquid Intake in Labor</brief_title>
  <official_title>Clear Liquids vs Enhanced Clear Liquids; Effect on Labor Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of the study is to see if the addition of a carbohydrate- and protein-enhanced gel
      during labor speeds labor and reduces the rate of cesarean delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients will be randomized to placebo or experimental arm of study. In the placebo arm,
      patients will receive standard clear liquid diet, which includes ginger ale, variety of fruit
      juices, and plain soup broth. The experimental arm will receive the standard clear liquid
      diet, and in addition will receive Accel Gel every 3 hours while in labor.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Actual">July 2017</completion_date>
  <primary_completion_date type="Actual">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time from admission to delivery</measure>
    <time_frame>Participants will be followed during labor until delivery, an expected range of 1-48 hours</time_frame>
    <description>Up to 3 days from time of admission</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of second stage of labor</measure>
    <time_frame>Participants will be followed during labor until delivery, an expected range of 1-48 hours</time_frame>
    <description>Time of complete cervical dilation to delivery of infant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>delivery in &lt;24 hours</measure>
    <time_frame>Participants will be followed during labor until delivery, an expected range of 1-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cesarean delivery</measure>
    <time_frame>Participants will be followed during labor until delivery, an expected range of 1-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of composite adverse GI outcome (vomiting or diarrhea)</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 5 days</time_frame>
    <description>Any vomiting or diarrhea</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>patient satisfaction with diet</measure>
    <time_frame>Participants will be followed during labor until delivery, an expected range of 1-48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Urine Ketones</measure>
    <time_frame>Participants will be followed during labor until full dilation, an expected range of 1-48 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Abnormal Labor</condition>
  <condition>Failed Induction of Labor</condition>
  <condition>Ketosis</condition>
  <arm_group>
    <arm_group_label>Usual Clear Diet</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>This intervention consists of soup broth, variety of juices (apple, cranberry, grape), ginger ale, water, and ice.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Accel Gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This intervention is an enhanced clear liquid gel is Accel Gel, produced by PacificHealth Labs of Matawan, NJ. This gel has 4:1 carb to protein ratio formula, and ingredients that are not contraindicated in pregnancy (only the flavors with minimal caffeine are used).
http://www.pacifichealthlabs.com/accel-gel-all-natural-rapid-energy-gel-product.html</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Accel Gel</intervention_name>
    <description>Accel Gel by PacificHealth Labs in Matawan, NJ.</description>
    <arm_group_label>Accel Gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Usual clear diet</intervention_name>
    <description>Usual clear liquids</description>
    <arm_group_label>Usual Clear Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Nulliparity (first baby)

          -  Admission with the intent to deliver vaginally

          -  Gestational age &gt;36 weeks

          -  Age â‰¥ 18

        Exclusion criteria:

          -  Planned cesarean delivery

          -  Renal Disease

          -  Preeclampsia

          -  Diabetes (Pre-gestational or Gestational)

          -  Allergy to any component of sports drink

          -  NPO diet by physician
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laura Goetzl, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Temple University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>August 15, 2014</study_first_submitted>
  <study_first_submitted_qc>August 12, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 14, 2015</study_first_posted>
  <last_update_submitted>June 8, 2018</last_update_submitted>
  <last_update_submitted_qc>June 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Abnormal Labor</keyword>
  <keyword>Prolonged Induction</keyword>
  <keyword>Ketosis</keyword>
  <keyword>Diet</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dystocia</mesh_term>
    <mesh_term>Ketosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

